Comparison of telemetry and high-definition oscillometry for blood pressure measurements in conscious dogs: Effects of torcetrapib

Journal of the American Association for Laboratory Animal Science

Volumn 49, Issue 4, 2010, Pages 464-471

  Meyer, Olivier ^a   Jenni, Roland ^a   Greiter Wilke, Andrea ^a   Breidenbach, Alexander ^a   Holzgrefe, Henry H ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TORCETRAPIB;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONSCIOUSNESS; DIASTOLIC BLOOD PRESSURE; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; HEART RATE; INTERMETHOD COMPARISON; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSCILLOMETRY; SYSTOLIC BLOOD PRESSURE; TELEMETRY; VOMITING;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DOGS; HEART RATE; OSCILLOMETRY; QUINOLINES; REPRODUCIBILITY OF RESULTS; TELEMETRY;

ANIMALIA; CANIS FAMILIARIS;

EID: 77956156800     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bland JM, Altman DG. 2007. Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat 17:571-582.
2. Bodey AR, Michell AR, Bovee KC, Buranakurl C, Garg T. 1996. Comparison of direct and indirect oscillometric measurements of arterial blood pressure in conscious dogs. Res Vet Sci 61:17-21. (Pubitemid 126504151)
3. Brooks D, Horner RL, Kozar LF, Waddell TK, Render CL, Phillipson EA. 1996. Validation of a telemetry system for long-term measurement of blood pressure. J Appl Physiol 81:1012-1018.
4. Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R. 2007. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 21:542-558. (Pubitemid 46814208)
5. Forrest MJ, Bloomfield D, Briscoe RJ, Brown PN, Cumiskey AM, Ehrhart J, Hershey JC, Keller WJ, Ma X, McPherson HE, Messina E, Peterson LB, Sharif RW, Siegl PKS, Sinclair PJ, Sparrow CP, Stevenson AS, Sun SY, Tsai C, Vargas H, Walker M 3rd, West SH, White V, Woltmann RF. 2008. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol 154:1465-1473.
6. Gains MJ, Grodecki KM, Jacobs RM, Dyson D, Foster RA. 1995. Comparison of direct and indirect blood pressure measurements in anesthetized dogs. Can J Vet Res 59:238-240.
7. Gesink J. 1999. Target practice: a BMET's guide to accuracy, precision, and resolution. Biomed Instrum Technol 33:427-430. (Pubitemid 29455836)
8. Gibaldi M, Perrier D. Pharmacokinetics. New York (NY): Marcel Dekker.
9. Haberman CE, Kang CW, Morgan JD, Brown SA. 2006. Evaluation of oscillometric and Doppler ultrasonic methods of indirect blood pressure estimation in conscious dogs. Can J Vet Res 70:211-217. (Pubitemid 44122740)
10. Hu X, Dietz JD, Xia C, Knight DR, Loging WT, Smith AH, Yuan H, Perry DA, Keiser J. 2009. Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology 150:2211-2219.
11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. [Internet]. 2005. S7B: the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. [2 Jul 2010]. Available at http://www.ich.org/LOB/media/MEDIA2192.pdf.
12. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. [Internet]. 2005. E14: the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. [2 Jul 2010]. Available at http://www.ich.org/LOB/ media/MEDIA1476.pdf.
13. Institute for Laboratory Animal Research. 1996. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press.
14. Liang B, Verrier RL, Melman J, Lown B. 1979. Correlation between circulating catecholamine levels and ventricular vulnerability during psychological stress in conscious dogs. Proc Soc Exp Biol Med 161:266-269. (Pubitemid 9222199)
15. MacFarlane PD, Grint N, Dugdale A. Comparison of invasive and non-invasive blood pressure monitoring during clinical anesthesia in dogs. Vet Res Commun 34:217-227
16. McMurphy RM, Stoll MR, McCubrey R. 2006. Accuracy of an oscillometric blood pressure monitor during phenylephrine-induced hypertension in dogs. Am J Vet Res 67:1541-1545. (Pubitemid 44400171)
17. Munir S, Guilcher A, Kamalesh T, Clapp B, Redwood S, Marber M, Chowienczyk P. 2008. Peripheral augmentation index defines the relationship between central and peripheral pulse pressure. Hypertension 51:112-118. (Pubitemid 350307112)
18. Pedersen KM, Butler MA, Ersbøll AK, Pedersen HD. 2002. Evaluation of an oscillometric blood pressure monitor for use in anesthetized cats. J Am Vet Med Assoc 221:646-650.
19. Perlman ME, Murdande SB, Gumkowski MJ, Shah TS, Rodricks CM, Thornton MJ, Freel D, Erhart LC. 2008. Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. Int J Pharm 351:15-22. (Pubitemid 351186838)
20. Polakowski JS, King AJ, Campbell TJ, Nelson RA, Preusser LC, Kempf GAJ, Marsh KC, Gintant GA, Cox BF, Mittelstadt SW. 2009. Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs. J Cardiovasc Pharmacol 54:543-551.
21. Prioli NA, Winbury MM. 1960. Indirect method for blood pressure determination in the dog. J Appl Physiol 15:323-324.
22. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. 2009. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 15:272-289.
23. Regan HK, Lynch JJ, Regan CP. 2009. Long-term assessment of blood pressure transducer drift in rhesus monkeys chronically instrumented with telemetry implants. J Pharmacol Toxicol Methods 59:35-38.
24. Rensen PCN, Jukema JW. 2008. Torcetrapib increases mortality in patients with a high risk of cardiovascular disorders. Ned Tijdschr Geneeskd 152:1088-1090. (Pubitemid 351805072)
25. Sawyer DC, Guikema AH, Siegel EM. 2004. Evaluation of a new oscillometric blood pressure monitor in isoflurane-anesthetized dogs. Vet Anaesth Analg 31:27-39. (Pubitemid 40208655)
26. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. 2000. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263-270. (Pubitemid 30311951)
27. Verrij E, van Montfrans G, Bos JW. 2008. Reintroduction of Riva-Rocci measurements to determine systolic blood pressure? Neth J Med 66:480-482.